Table 4.
No. | Gene | Accession | Nucleotide | Amino acid | Diseases (OMIM) | Zygosity | Global frequency (ExAC) | Korean frequency (KRGDB) | Inheritancea (OMIM) | ACMG |
---|---|---|---|---|---|---|---|---|---|---|
39 | *ABCC2 | NM_000392.3 | c.2443C > T | p.Arg815Ter | Dubin–Johnson syndrome | Hetero | 0.00002826 | AR | PVS1, PM2 | |
*ABCC2 | NM_000392.3 | c.2302C > T | p.Arg768Trp | Dubin–Johnson syndrome | Hetero | 0.00007539 | 0.000803859 | AR | PP3 | |
57 | MECP2 | NM_004992.3 | c.403A > G | p.Lys135Glu |
{Autism susceptibility, X-linked 3} Mental retardation Rett syndrome Encephalopathy, neonatal severe |
Hetero | XR, XD | PM2, PP3, PP5 | ||
60 | **Xp22.2p22.33 deletion | Hetero | ||||||||
**NLGN4X | NM_020742.3 | Whole gene deletion |
Asperger syndrome susceptibility Autism susceptibility Mental retardation |
Hetero | ||||||
63 | Xp22.31p22.33 deletion | Hetero | ||||||||
NLGN4X | NM_020742.3 | Whole gene deletion |
Asperger syndrome susceptibility Autism susceptibility Mental retardation |
Hetero | ||||||
66 | DLGAP2 | NM_004745.4 | Whole gene duplication | Autism spectrum disorder | Hetero | |||||
69 | AUTS2 | NM_015570.2 | c.2962dleG | p.Glu988LysfsTer37 | AUTS2 syndrome Mental retardation | Hetero | AD | PVS1, PM2 | ||
75 | SCN2A | Exon 15-16 deletion | Epileptic encephalopathy, early infantile | Hetero | AD | |||||
76 | KAT6A | NM_006766.3 | c.3456G > A | p.Trp1152Ter | Mental retardation | Hetero | PVS1, PM2 | |||
*CCDC50 | NM_178335.2 | c.82_83dupAC | p.Leu29ProsfsTer40 | ?Deafness, | Hetero | AD | PVS1, PM2 | |||
87 | HUWE1 | NM_031407.5 | c.693+1G > A | Mental retardation, syndromic, Turner type | Hetero | PVS1, PM2 | ||||
94 | **TSC2 | NM_000548.3 | c.4744_4746del | p.Ile1582dle |
Tuberous sclerosis-2 Lymphangioleiomyomatosis, somatic |
Hetero | AD | PM2, PM4, PM6 | ||
95 | **TSC2 | NM_000548.3 | c.2838_122G > A |
Tuberous sclerosis-2 Lymphangioleiomyomatosis, somatic |
Hetero | AD | PM2, PM6, PP5, PP4 | |||
96 | CACNG2 | NM_006078.3 | c.437-2A > G | Mental retardation | Hetero | AD | PVS1, PM2 | |||
98 | 15q24 deletion (2.2Mb) | |||||||||
121 | **MECP2 | NM_004992.3 | c.455C > G | p.Pro152Arg |
{Autism susceptibility, X-linked 3} Mental retardation Rett syndrome Encephalopathy, neonatal severe |
Hetero | XR, XD | PM2, PM5, PP3, PP5 | ||
133 | 14q31.3-32.12 deletion | Hetero | ||||||||
138 | *SLC26A4 | NM_000441.1 | c.2168A > G | p.His723Arg | Deafness with enlarged vestibular aqueduct; Pendred syndrome | Hetero | 0.0001 | 0.00401929 | AR | PP3,PP2,PP5 |
*SLC26A4 | NM_000441.1 | c.919-2A > G | Deafness with enlarged vestibular aqueduct; Pendred syndrome | Hetero | 0.0003 | 0.000803859 | AR | PVS1, PP5 | ||
142 | **SYNGAP1 | NM_006772.2 | c.980T > C | p.Leu327Pro | Mental retardation | Hetero | – | – | AD | PM2, PP5 |
Seventeen participants showed likely pathogenic variants. OMIM: Online Mendelian Inheritance in Man; ExAC, population frequency from The Exome Aggregation Consortium; KRGDB, population frequency from the Korean Reference Genome Database; AD, Autosomal dominant; AR. Autosomal recessive; XD, X-linked dominant; XR, X-linked recessive; ACMG, The American College of Medical Genetics and Genomics guideline (Richards et al., 2015); PVS, Very strong evidence of pathogenicity; PM, Moderate evidence of pathogenicity; PP, Supporting evidence of pathogenicity. aInheritance of the gene described in OMIM. BOLD: Clinical syndromes and diseases related to neurodevelopmental disorders (ASD, ID, epilepsy).